ArticleBritish journal of cancer2015

Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy.

Giuseppe Cardillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.